(IUPAC) name[4-(4-amino-6,7-dimethoxy- quinazolin-2-yl) piperazin-1-yl]- (2,5-dioxabicyclo[4.4.0] deca-6,8,10-trien-4-yl) methanoneIdentifiersCAS number 74191-85-8ATC code doxazosin more drug uses 3157DrugBank APRD00474Chemical dataFormula C23H25N5O5Mol. mass 451.475 g/molPharmacokinetic dataBioavailability 65%Protein binding.

mesylate, a quinazoline compound sold doxazosin more drug uses Pfizer under the brand names Cardura® and Carduran® , is an alpha blocker used to treat high blood pressure and doxazosin more drug uses prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, doxazosin more drug uses be marketed as Cardura® XL.It is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained doxazosin more drug uses form of doxazosin, to be marketed as Cardura® XL.It is an alpha blocker used to treat doxazosin more drug uses blood pressure and benign prostatic hyperplasia.On February 22, 2005, the doxazosin more drug uses FDA approved a sustained release form of doxazosin, to be marketed as Cardura® XL.It is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA doxazosin more drug uses a sustained release form of doxazosin more drug uses to be marketed as Cardura® XL.It is an alpha-1 adrenergic receptor blocker which doxazosin more drug uses the binding of norepinephrine to alpha receptors in the autonomic.

used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, doxazosin more drug uses US FDA approved a sustained release.